San Francisco Eye Institute

Name

San Francisco Eye Institute

Legal name

San Francisco Eye Institute

Website

https://sfeyeinstitute.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

San Francisco Eye Institute is a private Bay Area ophthalmology and optometry practice operating seven locations, offering cataract surgery, vision correction, glaucoma, corneal, and dry eye treatments.

Ownership category

akta.pro rank

Product category

Ophthalmology and Optometry Services

NAICS

Offices of Physicians (62111), Offices of Optometrists (62132), Offices of Other Health Practitioners (6213), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Ophthalmology Surgery Centers (HLAFAIAF), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI), Optometry Clinics (Primary Eye Care) (HLAKAKAB), Comprehensive Eye Exams & Vision Care (HLAKAKAA)

Keywords

• Ophthalmology services
• Cataract surgery
• Vision correction surgery
• Glaucoma treatment
• Comprehensive eye care

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive ophthalmology and optometry services including consultations, diagnostic testing, surgical procedures, and ongoing patient care. Services are billed to insurance providers and/or patients directly.
2. Surgical Procedures: One-time surgical revenue from procedures including cataract surgery, vision correction (ICL, LASIK, RLE), corneal cross-linking, and glaucoma treatments. Premium IOLs and advanced procedures may have additional out-of-pocket costs beyond insurance coverage.
3. Financing Programs: Partnership with CareCredit to provide patient financing for elective procedures not covered by insurance, allowing patients to pay over time for vision correction surgery, custom cataract surgery, and other services.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

San Francisco Eye Institute is a multi-location ophthalmology and optometry medical practice providing comprehensive eye care including routine eye exams, cataract surgery with advanced intraocular lenses, vision correction surgery (EVO ICL, LASIK, PRK, refractive lens exchange), glaucoma treatment (DSLT, MIGS), corneal cross-linking for keratoconus, iLux dry eye therapy, Valeda light therapy for dry AMD, oculoplastics, and advanced diagnostic testing. Services are delivered by a team of 10+ ophthalmologists and optometrists across seven Bay Area locations and are billed to insurance carriers and patients.

Product overview

San Francisco Eye Institute is an ophthalmology practice offering a comprehensive portfolio of eye care services centered around three core areas: vision correction surgery (EVO ICL, LASIK, PRK, Refractive Lens Exchange), cataract surgery (with advanced IOLs including RxSight Light Adjustable Lens and AcrySof IQ Vivity), and comprehensive eye care (glaucoma management with DSLT and MIGS procedures, dry eye treatment with iLux, corneal disease with cross-linking and transplants, oculoplastics, and Valeda light therapy for dry AMD). The practice also provides diagnostic services using advanced technology including Pentacam AXL Wave, OCT imaging, Humphrey Visual Field testing, and AvaGen genetic testing. Vision correction and cataract services can be financed through CareCredit. The practice operates a patient portal for payments and appointment scheduling.

Differentiator

Problem solved

Functional benefit

Products and services

• EVO ICL (Visian ICL) Vision Correction Implantable Collamer Lens (ICL) vision correction procedure for patients with nearsightedness, farsightedness, or astigmatism who want to reduce dependence on glasses and contacts. Suitable for patients with thinner corneas; the lens provides clear vision, UV protection, does not cause dry eye, and is reversible and upgradable.
• LASIK Laser-assisted refractive surgery that reshapes the cornea to correct nearsightedness, farsightedness, and astigmatism. Performed as a comfortable ~10-minute procedure with short recovery.
• PRK (Photorefractive Keratectomy) Laser eye surgery that reshapes the cornea by removing the outer layer of tissue; an alternative to LASIK for patients who are not ideal LASIK candidates.
• Refractive Lens Exchange (RLE) Replaces the eye's natural lens with an artificial intraocular lens to correct refractive errors. Ideal for patients who want to reduce dependence on eyeglasses or contact lenses, especially those with presbyopia or higher refractive errors.
• Cataract Surgery Surgical removal of a cloudy lens and replacement with a clear artificial intraocular lens to restore vision, reduce glare and light sensitivity, restore color vision, and improve vision with advanced IOLs.
• RxSight Light Adjustable Lens (LAL) Cataract Surgery Premium cataract surgery using the first and only FDA-approved Light Adjustable Lens (LAL), which allows the lens power to be fine-tuned after surgery via painless UV light treatments to match individual visual goals.
• Custom Cataract Surgery Packages Customized cataract surgery using advanced intraocular lenses designed to reduce or eliminate the need for glasses or contact lenses after surgery.
• Corneal Cross-Linking (Glaukos iLink) Minimally invasive outpatient procedure using prescription riboflavin eye drops and UV light therapy (Glaukos iLink KXL System) to strengthen and stiffen corneas, stopping progression of keratoconus or corneal ectasia.
• Direct Selective Laser Trabeculoplasty (DSLT) for Glaucoma Advanced non-invasive laser treatment that lowers intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Delivered externally without contact with the eye in approximately 2.4 seconds.
• Minimally Invasive Glaucoma Surgery (MIGS) — iStent and Hydrus Microstent Minimally invasive glaucoma surgery using specialized micro-implants (iStent titanium implants and the eyelash-sized Hydrus Microstent) to improve fluid drainage and reduce eye pressure, often performed in conjunction with cataract surgery.
• iLux Dry Eye Treatment FDA-approved in-office treatment using gentle heat and pressure to soften oil buildup and unblock meibomian glands, providing relief from dry eye caused by Meibomian Gland Dysfunction (MGD). Treatment takes less than 15 minutes.
• Valeda Light Therapy for Dry AMD First and only FDA-authorized light-based treatment using photobiomodulation (red, near-infrared, and yellow wavelengths) to improve visual function in patients with dry age-related macular degeneration. Non-invasive in-office treatment with no injections, surgery, or downtime.
• Oculoplastics (Eyelid and Facial Plastic Surgery) Specialized eyelid and facial plastic surgery procedures including blepharoplasty, brow lift, entropion and ectropion repair, tear duct surgery, BOTOX and injectables, and treatment for thyroid-related eye problems.
• Comprehensive Eye Exams and General Eye Care Full range of primary eye care services including screening for corneal disease, dry eyes, glaucoma, diabetic retinopathy, and macular degeneration, with thorough ophthalmic evaluation from eyelids to retina.
• Corneal Disease Treatment and Transplantation Specialty treatment for Fuchs' Dystrophy, pterygium, and keratoconus, including full corneal transplantation services (Penetrating Keratoplasty, DSAEK, DMEK).

Quantifiable outcome

• 4.9/5 average patient rating based on over 900 reviews
• +2 more outcomes

Named customers8 records

Segments7 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core.

• AlconcoreTechnology or IntegrationAlcon DSLT (Direct Selective Laser Trabeculoplasty) technology offered for glaucoma treatment. DSLT is an advanced non-invasive laser treatment for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
• RxSightcoreTechnology or IntegrationProvider of the only FDA-approved Light Adjustable Lens (LAL) used in cataract surgery, allowing post-operative vision adjustment through UV light treatments.
• GlaukoscoreTechnology or IntegrationProvider of the iLink KXL System, the only FDA-approved device for corneal cross-linking to treat keratoconus and corneal ectasia. Also provider of iStent and Hydrus Microstent for MIGS procedures.
• Alcon (Systane iLux)coreTechnology or IntegrationProvider of the Systane iLux device used for meibomian gland expression treatment of dry eye caused by MGD.
• Alcon (Valeda)coreTechnology or IntegrationProvider of Valeda Light Delivery System, the first and only FDA-authorized light-based treatment for dry age-related macular degeneration using photobiomodulation.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SFEyeInstitute
• Instagraminstagram.com/sfeyeinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about San Francisco Eye Institute